AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Adsunib 12.5 Capsule

Prescription Icon
Prescription Required

Marketer

Adley Formulations

Salt Composition

Sunitinib (12.5mg)

Overview Adsunib 12.5 Capsule

Suninib 12.5mg capsules are prescribed for kidney cancer and gastrointestinal stromal tumors. Their mechanism involves inhibiting specific enzymes crucial for cancer cell proliferation, thus reducing tumor size and growth rate. These capsules may be administered with or without food, but consistent daily timing optimizes effectiveness. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's instructions; incorrect usage or overdosing can lead to severe adverse effects. Therapeutic benefits might not be immediately apparent, often taking weeks or months; discontinue only under medical guidance. Common side effects include fatigue, loose stools, nausea, vomiting, altered taste perception, and reduced appetite. Regular blood pressure and thyroid function monitoring may be recommended. This medication can lower blood glucose, potentially causing hypoglycemia and fainting; diabetics should monitor their blood sugar frequently and discuss potential anti-diabetic medication adjustments with their physician. Prior to commencing treatment, inform your doctor of any pre-existing heart, liver, kidney, or bleeding disorders. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout the treatment period.

Uses of Adsunib 12.5 Capsule

Managing Renal Cell Carcinoma and Gastrointestinal Stromal Tumors

Major Benefits of Adsunib 12.5 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Adsunib 12.5mg capsules. These capsules can be ingested with or without food, although consistent timing is recommended.

Common Side effects of Adsunib 12.5 Capsule:

  • Hand-foot syndrome
  • Bleeding disorder
  • Low blood platelets
  • Decreased appetite
  • Nausea
  • Vomiting
  • Weakness
  • Abdominal pain
  • Indigestion
  • High blood pressure
  • Diarrhea
  • Stomatitis (Inflammation of the mouth)
  • Taste change

How to use Adsunib 12.5 Capsule:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Adsunib 12.5mg capsules can be administered with or without food, however, consistent timing is recommended.

How Adsunib 12.5 Capsule works:

Adsunib 12.5mg capsules are an anticancer drug that inhibits the activity of specific cell surface tyrosine kinases, thereby disrupting cancer cell growth signals. Its mechanism also includes limiting angiogenesis, the formation of new blood vessels supplying the tumor, thus curbing malignant tumor expansion.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction of Adsunib 12.5 Capsule with alcohol is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Adsunib 12.5mg capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Adsunib 12.5 mg capsules while breastfeeding is likely inadvisable. Scant evidence in humans indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking Adsunib 12.5 Capsules might lead to adverse effects impacting driving capabilities. Dizziness is a possible side effect of Adsunib 12.5 Capsule treatment. Refrain from driving or operating machinery should dizziness occur while using this medication.

KidneyKidneySAFE IF PRESCRIBED

Adsunib 12.5 mg capsules can be administered to patients with renal impairment without the need for dosage modification.

LiverLiverSAFE IF PRESCRIBED

Adsunib 12.5 mg capsules can be administered to patients with hepatic impairment without necessitating a dosage modification.

What if you forget to take Adsunib 12.5 Capsule :

Omit any missed Adsunib 12.5 Capsule dose and resume your regular medication regimen. Avoid taking a double dose.

Facts to Know About Adsunib 12.5 Capsule

LabelValue
Type of Compound Indole- and pyrrole-containing compounds
Addictive None.
Type of Medication Cancer-fighting medications

FAQs on Adsunib 12.5 Capsule

Follow your physician's instructions precisely when using Adsunib 12.5 Capsule. Prescribing should be limited to oncologists experienced in cancer therapy. Administer once daily, with or without food. Avoid grapefruit and grapefruit juice throughout your Adsunib 12.5 Capsule treatment to minimize potential adverse reactions.
Adsunib 12.5 Capsule treatment may result in skin lightening and hair loss. Patients might also develop dry, thickened, or cracked skin, blisters, or rashes on their hands and feet. These effects typically resolve upon discontinuation of the medication. However, Adsunib 12.5 Capsule can also induce severe, potentially life-threatening skin reactions, including severe rashes or rapidly progressing skin ulceration. Report any signs of infection near a skin wound to your physician without delay. This includes symptoms such as fever, pain, redness, swelling, or the discharge of pus or blood.
Taking Adsunib 12.5 Capsules carries a risk of life-threatening, severe liver complications. Report itching, jaundice (yellowing of eyes or skin), dark urine, or right upper abdominal pain or discomfort to your physician immediately. Liver function blood tests will be conducted before and throughout your Adsunib 12.5 Capsule treatment. Should liver problems arise, your doctor might suspend or discontinue your medication.
Adsunib 12.5 Capsule currently lacks generic alternatives. Its mechanism involves inhibiting a protein kinase enzyme, a molecule found on the surface of cancerous cells that drives their proliferation and metastasis. This enzymatic blockade thus impedes cancer progression. Erlotinib, gefitinib, lapatinib, vemurafenib, and dasatinib represent other examples of protein kinase inhibitors.
Clinical evidence is lacking to validate the concurrent use of Adsunib 12.5 Capsule with other chemotherapeutic agents. Its application in Gastrointestinal stromal tumors (GIST), a malignancy affecting the stomach and intestines, is typically reserved for cases where imatinib, an alternative anticancer drug, proves ineffective or is contraindicated.
Adsunib 12.5 mg capsules can lower blood glucose. Diabetic patients should monitor their blood sugar closely as it may drop dangerously low, potentially causing loss of consciousness. Adjustments to antidiabetic medication dosage may be necessary based on these blood sugar readings.
Adsunib 12.5 Capsule frequently elevates blood pressure. Consequently, consistent blood pressure monitoring is crucial. Report severe headaches, dizziness, lightheadedness, or visual disturbances to your physician immediately. They may initiate antihypertensive therapy or temporarily suspend treatment until your blood pressure normalizes.
Adsunib 12.5 Capsule
1,519
MRP 1,850
17% off